To further explore whether the effect of MAP3K15 on diabetes is independent of obesity, we evaluated whether European individuals with a loss of MAP3K15 are at a lower risk of developing diabetes even after adjusting for BMI. This evidence concerns the gene MAP3K15 and obesity due to melanocortin 4 receptor deficiency.